Conversely, in HPV-negative tumours, p53 is inactivated by gene mutation, while pRb is inhibited by cyclin D1 or cyclin D2 and cyclin-dependent kinases (CDK-)4-6 complexes. The gene discussed is TP53; the disease is neoplasm.